News Focus
News Focus
icon url

meirluc

07/30/24 9:49 PM

#709381 RE: skitahoe #709376

Gary, you do have a point that publicity may matter a lot but
this may take some months before more information is
disseminated about UK patients undergoing this new
immunotherapeutic treatment whereas the publicity would
have spread even faster if approval had been obtained in a larger
market (e.g. USA).

Furthermore, with time, the lawsuit could also generate good
publicity especially if a few rapid settlements could be arranged
with the criminals or articles begin to appear in the press concerning
a trial that Laura Posner may be pursuing.

Given enough time, all of this may indirectly keep the SP from
falling of the cliff.

Once Flaskworks comes on board and a major partnership is sealed,
everything will start to look even better but that again may take some time.
icon url

Karlchen

07/31/24 9:14 AM

#709430 RE: skitahoe #709376

HOPE in our case it's different, but in the recent past i have two holdings with approval the price went down and now small sales IBRX IOVA and the sp declines further!
but as i always say, the next years will be great anyway
icon url

Investor082

07/31/24 9:32 AM

#709434 RE: skitahoe #709376

Everyone said the same thing about JAMA, TLD, MIA, etc. I doubt things will change on UK approval news. This management doesn't have the skills and the right team to build that kind of energy and excitement. We’d have seen it otherwise. Of course, one can continue to live in denial.

The shorts will not stop and continue to attack even after approval. No reimbursement, no money to scale, etc. Took 4 years to get approval in 1 small jurisdiction after diluting couple of hundred million shares and still no reimbursement.